Share Prices & Company Research

Market News

01 Mar 2021 | 12:54

MyHealthChecked downplays speculation over 'significant' new contract

(Sharecast News) - AIM-listed personalised healthcare company MyHealthChecked noted the jump in its share price on Monday as it downplayed weekend speculation that a significant potential contract is in the pipeline. The group said that as notified in December, its Covid-19 testing service has been added to the UK government's approved Covid-19 private testing providers list for General Testing, and the Test to Release for International Travel scheme introduced on 15 December.

"Whilst the company is engaged in commercial discussions with a number of parties for the supply of Covid-19 testing kits, no contracts have been signed to date, nor is there any certainty that any of these discussions will result in commercial agreement," it said.

At 1250 GMT, the shares were up 23% at 4p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.